339 related articles for article (PubMed ID: 29197748)
21. Cell sheet engineering for regenerative medicine: current challenges and strategies.
Owaki T; Shimizu T; Yamato M; Okano T
Biotechnol J; 2014 Jul; 9(7):904-14. PubMed ID: 24964041
[TBL] [Abstract][Full Text] [Related]
22. Delivery of synthetic mRNAs for tissue regeneration.
Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M
Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530
[TBL] [Abstract][Full Text] [Related]
23. ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity.
Son S; Park M; Kim J; Lee K
Adv Sci (Weinh); 2024 May; 11(18):e2307541. PubMed ID: 38447169
[TBL] [Abstract][Full Text] [Related]
24. Design of
Tusup M; French LE; De Matos M; Gatfield D; Kundig T; Pascolo S
Chimia (Aarau); 2019 May; 73(5):391-394. PubMed ID: 31118121
[TBL] [Abstract][Full Text] [Related]
25. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
[TBL] [Abstract][Full Text] [Related]
26. pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences.
Grier AE; Burleigh S; Sahni J; Clough CA; Cardot V; Choe DC; Krutein MC; Rawlings DJ; Jensen MC; Scharenberg AM; Jacoby K
Mol Ther Nucleic Acids; 2016 Apr; 5(4):e306. PubMed ID: 27093168
[TBL] [Abstract][Full Text] [Related]
27. An overview of rational design of mRNA-based therapeutics and vaccines.
To KKW; Cho WCS
Expert Opin Drug Discov; 2021 Nov; 16(11):1307-1317. PubMed ID: 34058918
[TBL] [Abstract][Full Text] [Related]
28. Non-viral gene transfection technologies for genetic engineering of stem cells.
Jo J; Tabata Y
Eur J Pharm Biopharm; 2008 Jan; 68(1):90-104. PubMed ID: 17870447
[TBL] [Abstract][Full Text] [Related]
29. The potential role of telocytes in Tissue Engineering and Regenerative Medicine.
Boos AM; Weigand A; Brodbeck R; Beier JP; Arkudas A; Horch RE
Semin Cell Dev Biol; 2016 Jul; 55():70-8. PubMed ID: 26805441
[TBL] [Abstract][Full Text] [Related]
30. Biomarker discovery and biotherapeutics applications of photosynthetic light-harvesting and bioluminescence light-emitting chromophore-protein complexes in stem cell biology and regenerative medicine.
Koka PS
J Stem Cells; 2014; 9(3):127-33. PubMed ID: 25157447
[TBL] [Abstract][Full Text] [Related]
31. Intracellular Availability of pDNA and mRNA after Transfection: A Comparative Study among Polyplexes, Lipoplexes, and Lipopolyplexes.
Gonçalves C; Akhter S; Pichon C; Midoux P
Mol Pharm; 2016 Sep; 13(9):3153-63. PubMed ID: 27486998
[TBL] [Abstract][Full Text] [Related]
32. Liver regenerative medicine: advances and challenges.
Chistiakov DA
Cells Tissues Organs; 2012; 196(4):291-312. PubMed ID: 22572238
[TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi specific mRNA amplification by in vitro transcription improves parasite transcriptomics in host-parasite RNA mixtures.
Kessler RL; Pavoni DP; Krieger MA; Probst CM
BMC Genomics; 2017 Oct; 18(1):793. PubMed ID: 29037144
[TBL] [Abstract][Full Text] [Related]
34. Engineering physical microenvironment for stem cell based regenerative medicine.
Han YL; Wang S; Zhang X; Li Y; Huang G; Qi H; Pingguan-Murphy B; Li Y; Lu TJ; Xu F
Drug Discov Today; 2014 Jun; 19(6):763-73. PubMed ID: 24508818
[TBL] [Abstract][Full Text] [Related]
35. Unifying in vitro and in vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction.
Bhosle SM; Loomis KH; Kirschman JL; Blanchard EL; Vanover DA; Zurla C; Habrant D; Edwards D; Baumhof P; Pitard B; Santangelo PJ
Biomaterials; 2018 Mar; 159():189-203. PubMed ID: 29331806
[TBL] [Abstract][Full Text] [Related]
36. Stem cell bioprinting for applications in regenerative medicine.
Tricomi BJ; Dias AD; Corr DT
Ann N Y Acad Sci; 2016 Nov; 1383(1):115-124. PubMed ID: 27870077
[TBL] [Abstract][Full Text] [Related]
37. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
Devoldere J; Dewitte H; De Smedt SC; Remaut K
Drug Discov Today; 2016 Jan; 21(1):11-25. PubMed ID: 26210957
[TBL] [Abstract][Full Text] [Related]
38. Tissue Engineering and Regenerative Medicine 2015: A Year in Review.
Wobma H; Vunjak-Novakovic G
Tissue Eng Part B Rev; 2016 Apr; 22(2):101-13. PubMed ID: 26714410
[TBL] [Abstract][Full Text] [Related]
39. Clinically relevant aspects of stem cell technologies: current state of play.
Stuart MJ; Pattavilakom A
ANZ J Surg; 2015 Sep; 85(9):615-9. PubMed ID: 25267417
[TBL] [Abstract][Full Text] [Related]
40. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA.
Baiersdörfer M; Boros G; Muramatsu H; Mahiny A; Vlatkovic I; Sahin U; Karikó K
Mol Ther Nucleic Acids; 2019 Apr; 15():26-35. PubMed ID: 30933724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
